dinox GmbH

Dinox GmbH, based in Berlin, Germany, is a leading company in the field of clinical research for women's health. The focus is on the female participants, ensuring smooth organization of cycle-dependent procedures such as daily transvaginal ultrasounds (TVUS) and frequent blood draws. With over 30 years of experience in the development of medications related to female fertility, dinox supports treatment areas such as contraception, endometriosis therapy, fertility treatment, hormone replacement therapy, and sexology.

The main focus is on proof-of-concept and dose-finding studies. Many of the studies conducted have significantly contributed to the market approval of successful pharmaceuticals.

Dinox is renowned for its excellent data and sample quality. This is thanks to a highly qualified team of experienced gynecologists, an established quality management system, and fully medically trained study personnel. A dedicated study physician is available around the clock to address participants' health concerns. A sophisticated recruitment system ensures that studies are conducted on time and with the highest quality. The study center, located in the heart of Berlin, near the Charité and Humboldt University, offers a welcoming atmosphere and is easily accessible.

Dinox's service portfolio includes the reliable execution of outpatient studies with the highest quality standards across all phases of clinical research:

• Phase I: Pharmacokinetic and pharmacodynamic studies, as well as interaction studies

• Phase II: Proof-of-concept studies, such as ovulation inhibition and ovarian stimulation

• Phase III: Large-scale studies such as Pearl Index and cycle control studies

• Phase IV: Post-approval monitoring and comparison studies

Dinox GmbH stands for flexibility, quality, and an experienced team that specializes in meeting the unique demands of gynecological research.